Effects of intrauterine infusion of oestradiol-17β and prostaglandin E-2 on luteal function in non-pregnant heifers
in ReproductionSearch for other papers by L. P. Reynolds in
Current site
Google Scholar
PubMed
Search for other papers by D. A. Robertson in
Current site
Google Scholar
PubMed
Search for other papers by S. P. Ford in
Current site
Google Scholar
PubMed
Summary. Non-pregnant heifers (4/group) received intrauterine infusions of vehicle, oestradiol-17β (150 ng), PGE-2 (250 μg), or oestradiol + PGE-2 every 6 h from 12:00 h on Day 13 to 06:00 h on the day of subsequent oestrus or 06:00 h on Day 21 (day of oestrus = Day 0). Ten of 12 heifers receiving vehicle, oestradiol or PGE-2 returned to oestrus by Day 21, whereas none of the heifers receiving oestradiol + PGE-2 returned to oestrus by Day 21. Jugular venous progesterone concentrations of vehicle- and PGE-2-treated heifers declined rapidly after Day 15 and were basal (< 1 ng/ml) by Day 20. For heifers receiving oestradiol infusions, systemic progesterone levels did not decline until after Day 18, but were again basal by Day 20. Heifers treated with oestradiol + PGE-2 maintained elevated systemic progesterone levels until Day 21 after oestrus. In addition, the corpora lutea of the heifers treated with oestradiol + PGE-2 were heavier (P < 0·01) and contained more (P < 0·05) progesterone than did corpora lutea of the heifers in the other 3 groups on Day 21 (3·4 g and 19·52 μg/g and 1·2 g and 1·65 μg/g, respectively). It is concluded that oestradiol-17β and PGE-2, both of which are produced by the bovine conceptus and secreted from the gravid uterus, may act synergistically to maintain luteal function during early pregnancy in the cow.
Reproduction is committed to supporting researchers in demonstrating the impact of their articles published in the journal.
The two types of article metrics we measure are (i) more traditional full-text views and pdf downloads, and (ii) Altmetric data, which shows the wider impact of articles in a range of non-traditional sources, such as social media.
More information is on the Reasons to publish page.
| Sept 2018 onwards | Past Year | Past 30 Days | |
|---|---|---|---|
| Full Text Views | 201 | 80 | 0 |
| PDF Downloads | 88 | 26 | 0 |
Online ISSN: 1741-7899
Print ISSN: 1470-1626
Strengthening biomedical communities
to advance science and health
CONTACT US
Bioscientifica Ltd | Starling House | 1600 Bristol Parkway North | Bristol BS34 8YU | UK
Bioscientifica Ltd | Registered in England no 3190519